feed,title,long_url,short_url
Benzinga,"Turning Point's RET Inhibitor Candidate Shows Tolerable Safety Profile, Early Signals Of Activity In Solid Tumor Settings",https://benzinga.com/general/biotech/21/04/20495393/turning-points-ret-inhibitor-candidate-shows-tolerable-safety-profile-early-signals-of-activity-i,https://j.mp/3wqguWJ
